David VanderWeele, MD, PhD

An associate professor

Published Articles (1)

Enfortumab Vedotin Plus Pembrolizumab Reshapes Bladder Cancer, From Metastatic Disease to Surgery

August 26, 2026

For decades, platinum-based chemotherapy (cisplatin- or carboplatin-based regimens combined with gemcitabine) was the mainstay of treatment for metastatic urothelial cancer, with little improvement from added agents.